odyssey clx imaging system (LI-COR)
99
Structured Review
LI-COR
odyssey clx imaging system
Odyssey Clx Imaging System, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 90404 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/odyssey+imaging+system/Odyssey+CLx+Imaging+System/custom%409141-10%4042701686
Average 99 stars, based on 90404 article reviews
Odyssey Clx Imaging System, supplied by LI-COR, used in various techniques. Bioz Stars score: 99/100, based on 90404 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/odyssey+imaging+system/Odyssey+CLx+Imaging+System/custom%409141-10%4042701686
Average 99 stars, based on 90404 article reviews
odyssey clx imaging system - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Imaging:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Membrane:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Incubation:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Control:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Software:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Construct:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Saline:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Plasmid Preparation:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Milk:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Transfection:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Western Blot:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Fluorescence:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Mutagenesis:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Blocking Assay:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Expressing:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Fluorescence Microscopy:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Microscopy:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Immunohistochemistry:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, Staining:Article Title: Givinostat enhances antisense oligonucleotide efficacy in the mdx52 model of Duchenne muscular dystrophy Article Snippet: e was probed with a primary rabbit polyclonal antibody against MYOM3 (Proteintech, Manchester, UK), followed by incubation with a secondary goat anti-rabbit antibody (IRDye 800CW Goat anti-rabbit IgG, |